| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CMMI.87 |
| P698 | PubMed publication ID | 17193596 |
| P50 | author | Luce Vander Elst | Q98150762 |
| P2093 | author name string | Sophie Laurent | |
| Robert N Muller | |||
| Sébastien Boutry | |||
| P2860 | cites work | Structure of a C-type carbohydrate recognition domain from the macrophage mannose receptor | Q27622317 |
| Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture | Q30670198 | ||
| A peptide mimic of selectin ligands abolishes in vivo inflammation but has no effect on the rat heart allograft survival1. | Q31097495 | ||
| Molecular magnetic resonance imaging with targeted contrast agents | Q33193603 | ||
| Scavenger endothelial cells of vertebrates: a nonperipheral leukocyte system for high-capacity elimination of waste macromolecules | Q34064706 | ||
| Imaging infection/inflammation in the new millennium | Q34220057 | ||
| Inflammatory Reactions in the Pathogenesis of Atherosclerosis | Q35124954 | ||
| Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease | Q35599842 | ||
| A T cell-dependent experimental liver injury in mice inducible by concanavalin A | Q35603939 | ||
| Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging. | Q36769952 | ||
| Human macrovascular endothelial cells: optimization of culture conditions | Q41725074 | ||
| Magnetic labeling of activated microglia in experimental gliomas | Q41894453 | ||
| MR molecular imaging of early endothelial activation in focal ischemia | Q44965449 | ||
| Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent. | Q46411714 | ||
| MRI detection of early endothelial activation in brain inflammation | Q47227813 | ||
| MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. | Q47741949 | ||
| In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance | Q48261648 | ||
| Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits | Q50507177 | ||
| Biodistribution of ultrasmall iron oxide particles in the rat liver | Q57188603 | ||
| Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies | Q57189197 | ||
| Sublobular veins as the main site of lymphocyte adhesion/transmigration and adhesion molecule expression in the porto-sinusoidal-hepatic venous system during concanavalin A-induced hepatitis in mice | Q73308046 | ||
| The role of chemokines and adhesion molecules in the pathogenesis of rheumatoid arthritis | Q73401708 | ||
| Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets | Q73814011 | ||
| Correlation between clinical status and macrophage activity imaging in the central nervous system of rats | Q74133737 | ||
| Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles | Q74280205 | ||
| Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function | Q77698878 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | contrast agent | Q6849688 |
| P304 | page(s) | 15-22 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Contrast Media & Molecular Imaging | Q2995750 |
| P1476 | title | Specific E-selectin targeting with a superparamagnetic MRI contrast agent | |
| P478 | volume | 1 |
| Q53548189 | A simple one pot purification of bacterial amylase from fermented broth based on affinity toward starch-functionalized magnetic nanoparticle. |
| Q33382353 | Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models |
| Q39736444 | Can we accurately quantify nanoparticle associated proteins when constructing high-affinity MRI molecular imaging probes? |
| Q35093966 | Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. |
| Q57814135 | Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers |
| Q35538266 | Cytotoxic effects and the mechanism of three types of magnetic nanoparticles on human hepatoma BEL-7402 cells |
| Q37631874 | Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. |
| Q43995004 | Detection of vascular cell adhesion molecule-1 expression with USPIO-enhanced molecular MRI in a mouse model of cerebral ischemia |
| Q38467403 | Development of magnetic chromatography to sort polydisperse nanoparticles in ferrofluids |
| Q36900233 | Differential Impact of Plasma Proteins on the Adhesion Efficiency of Vascular-Targeted Carriers (VTCs) in Blood of Common Laboratory Animals |
| Q33917755 | Enabling individualized therapy through nanotechnology |
| Q37855912 | Glycoconjugate probes and targets for molecular imaging using magnetic resonance |
| Q30485161 | Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease |
| Q36447488 | Identification and treatment of symptoms associated with inflammation in medically ill patients |
| Q39485934 | In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. |
| Q50239173 | In vitro evaluation of the L-peptide modified magnetic lipid nanoparticles as targeted magnetic resonance imaging contrast agent for the nasopharyngeal cancer. |
| Q33852478 | Magnetic iron oxide nanoparticles for biomedical applications |
| Q38206265 | Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles |
| Q34823410 | Molecular magnetic resonance contrast agents for the detection of cancer: past and present |
| Q38946727 | Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo |
| Q37314628 | Multifunctional and stimuli-sensitive pharmaceutical nanocarriers |
| Q28543040 | Plasma protein corona modulates the vascular wall interaction of drug carriers in a material and donor specific manner |
| Q37794017 | Principles and basic concepts of molecular imaging |
| Q92136763 | RETRACTED ARTICLE: A Comparative Study of the Toxicity of Polyethylene Glycol–Coated Cobalt Ferrite Nanospheres and Nanoparticles |
| Q37883126 | Stabilization and functionalization of iron oxide nanoparticles for biomedical applications |
| Q57340453 | Superparamagnetic Iron Oxide Nanoparticles for MRI |
| Q38425098 | Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging. |
| Q36015388 | Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis |
| Q37787083 | Target: ligand interactions of the vascular endothelium. Implications for molecular imaging in inflammation |
| Q89732159 | The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins |
| Q92236760 | Ultrasmall superparamagnetic nanoparticles targeting E-selectin: synthesis and effects in mice in vitro and in vivo |
Search more.